| Ken Schramm, | |
|
4230 Don King Rd, Ketchikan, AK 99901-9047 | |
| (907) 247-2183 | |
| Not Available |
| Full Name | Ken Schramm |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 4230 Don King Rd, Ketchikan, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255888665 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 114494 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ken Schramm, 4230 Don King Rd, Ketchikan, AK 99901-9047 Ph: (907) 247-2183 | Ken Schramm, 4230 Don King Rd, Ketchikan, AK 99901-9047 Ph: (907) 247-2183 |
News Archive
An intensive program of surveillance, precautions, training and feedback in a large multihospital institution appears to be associated with reductions in rates of methicillin-resistant Staphylococcus aureus (MRSA) over a 15-year period, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
QLT Inc. today announced final 24-month results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with exudative (wet) age-related macular degeneration. The purpose of the study was to determine if Visudyne® combined with Lucentis® reduced retreatment rates compared with Lucentis monotherapy, while maintaining similar vision outcomes and an acceptable safety profile.
AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company's transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.
In the midst of a national healthcare overhaul, John Rittenhouse, CEO and chairman of Cavallino Consulting, LLC, candidly addresses main issues in the healthcare arena, and offers cures for the operational inefficiencies breaking the current system in his new, accessible guide titled Healthcare, Heal Thyself.
Lowering costs and improving patient outcomes are common goals for most health care providers. A new study from Creighton University School of Medicine and Center for Interprofessional Practice, Education and Research, published Aug. 12 in the Annals of Family Medicine, yielded a reduction in health care costs in an especially vulnerable group: high risk patients.
› Verified 1 days ago
Kalli Kline, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3526 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-6186 | |
Maxx Ritchie Keizer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 | |
Jacob Pignone, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2417 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-1960 Fax: 907-228-1919 | |
Kristin Frye, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4230 Don King Rd, Ketchikan, AK 99901 Phone: 907-247-2183 Fax: 907-247-2187 | |
Dr. Liliana B Boardman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2960 Tongass Ave, Ketchikan, AK 99901 Phone: 907-228-4900 Fax: 907-228-5232 | |
Danielle Steepe, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4230 Don King Rd, Ketchikan, AK 99901 Phone: 907-247-2183 | |
Torrie Jayne Borch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3526 Tongass Ave, Ketchikan, AK 99901 Phone: 907-225-6186 |